Validating artificial intelligence effectiveness defined Lung nodule malignancy score in patients with pulmonary nodule. - CREATE

Study identifier:D133FR00178

ClinicalTrials.gov identifier:NCT05817110

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Prospective Realworld Cohort Study to Validate Effectiveness of an Artificial Intelligence defined Lung Nodule Malignancy Score in Patients with Pulmonary Nodule Multicentric, multinational, prospective, observational study.

Medical condition

Lung Malignancy

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

700

Study type

Observational

Age

35 Years - n/a

Date

Study Start Date: 20 Apr 2023
Estimated Primary Completion Date: 20 Apr 2026
Estimated Study Completion Date: 30 Sept 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: Screening

Verification:

Verified 01 Jun 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria